US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.680
  • +0.030+1.82%
Close Feb 26 16:00 ET
  • 1.670
  • -0.010-0.60%
Pre 05:15 ET
52.16MMarket Cap-0.85P/E (TTM)

About Immuneering Company

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolIMRX
Company NameImmuneering
Listing DateJul 30, 2021
Issue Price15.00
Founded2008
CEODr. Benjamin J. Zeskind, PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address245 Main Street,2nd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-500-8080
Websitehttp://www.immuneering.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Benjamin J. Zeskind, PhD
  • President, Chief Executive Officer and Director
  • 1.92M
  • Dr. Brett Hall, PhD
  • Chief Scientific Officer
  • 1.40M
  • Mallory Morales
  • Chief Accounting Officer, Principal Financial Officer and Treasurer
  • --
  • Harold Eugene Brakewood
  • Chief Business Officer
  • 1.47M
  • Leah R. Neufeld
  • Chief People Officer
  • --
  • Michael D. Bookman
  • Chief Legal Officer and Secretary
  • --
  • Ann E. Berman
  • Chairman of the Board and Lead Independent Director
  • 181.38K
  • Dr. Thomas J. Schall, PhD
  • Director
  • --
  • Laurie B. Keating, J.D.
  • Independent Director
  • 179.88K
  • Robert J. Carpenter
  • Independent Director
  • 202.74K
  • Peter Feinberg
  • Independent Director
  • 165.67K
  • Dr. Diana F. Hausman, M.D.
  • Independent Director
  • 175.38K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+5.09%
NVIDIA
NVDA
+3.67%
Meta Platforms
META
+2.46%
Oracle
ORCL
+2.33%
Amazon
AMZN
+0.73%

Unlock the Full List